Related Experiment Video
Updated: Aug 20, 2026

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
Published on: August 30, 2024
Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy
Giorgia Beffagna1, Gianluca Occhi, Andrea Nava
1Department of Biology, University of Padua, Via Ugo Bassi 58/B 35131 Padua, Italy.
Insights
Researchers identified the transforming growth factor-beta3 (TGFbeta3) gene as the cause of arrhythmogenic right ventricular cardiomyopathy type 1 (ARVD1). This discovery aids in early diagnosis for families at risk of sudden cardiac death.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genetic Disease Research
Background:
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic heart condition.
- It involves fibro-fatty tissue replacing the right ventricle, increasing sudden death risk.
- The specific gene for ARVD1 remained unknown despite mapping to chromosome 14q24.3.
Purpose of the Study:
- To identify the gene responsible for arrhythmogenic right ventricular cardiomyopathy type 1 (ARVD1).
- To pinpoint the genetic basis of a specific form of ARVC.
- To advance genetic diagnostics for ARVC patients and their families.
Main Methods:
- Direct sequencing of the TGFbeta3 gene's promoter and UTRs in an ARVD1 family.
- DHPLC screening for mutations in unrelated ARVC patients.
- In vitro expression assays to assess the functional impact of identified mutations.
Main Results:
- A nucleotide substitution (c.-36G>A) in the 5' UTR of TGFbeta3 was found in affected ARVD1 family members.
- An additional mutation (c.1723C>T) in the 3' UTR of TGFbeta3 was identified in an unrelated ARVC patient.
- Mutated UTRs demonstrated a twofold increase in activity compared to wild-type sequences in vitro. Neither mutation was present in 300 controls.
Conclusions:
- TGFbeta3 is identified as the causative gene for ARVD1.
- This finding provides a new target for genetic screening.
- Early diagnosis of asymptomatic carriers within ARVC families is now more feasible.
Objective:
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetically heterogeneous disorder characterized by fibro-fatty replacement of the right ventricular myocardium, associated with high risk of sudden death. The objective of this study is to identify the gene involved in ARVD1, which has been elusive ever since its locus was mapped to chromosome 14q24.3.
Methods And Results:
Mutation screening of the promoter and untranslated regions (UTRs) of the transforming growth factor-beta3 (TGFbeta3) gene was performed by direct sequencing of genomic DNA of one index case belonging to an ARVD1 family including 38 members in four generations. We detected a nucleotide substitution (c.-36G>A) in 5' UTR of TGFbeta3 gene, invariably associated with the typical ARVC clinical phenotype in the affected family members, according to the established diagnostic criteria. Investigation extended to 30 unrelated ARVC patients, performed by denaturing high-performance liquid chromatography (DHPLC), led to the identification of an additional mutation (c.1723C>T) in the 3' UTR of one proband. Neither nucleotide change was found in 300 control subjects. In vitro expression assays with constructs containing the mutations showed that mutated UTRs were twofold more active than wild-types.
Conclusion:
We identified TGFbeta3 as the disease gene involved in ARVD1. The identification of a novel ARVC gene will increase the power of the genetic screening for early diagnosis of asymptomatic carriers among relatives of ARVC patients.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mechanism of Cardiac Arrhythmias
Cardiomyopathy IV: Restrictive Cardiomyopathy
Dysrhythmias III: Characteristics of Dysrhythmias
Mitral Regurgitation I: Introduction
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias